Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation
β Scribed by Matthew R. Foxton; Stewart Kendrick; Elizabeth Sizer; Paolo Muiesan; Mohammed Rela; Julia Wendon; Nigel D. Heaton; John G. O'Grady; Michael A. Heneghan
- Book ID
- 110916748
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 140 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We examined the relationship between the total cost incurred by liver transplantation (LT) recipients and their Model for End-Stage Liver Disease (MELD) score at the time of transplant. We used a novel database linking billing claims from a large private payer with the Organ Procurement and Transpla
The proportion of patients undergoing liver transplantation (LT) with renal insufficiency has significantly increased in the Model for End-Stage Liver Disease (MELD) era. This study was designed to determine the incidence and predictors of post-LT chronic renal failure (CRF) and its effect on patien
Studies have shown that liver transplantation offers no survival benefits to patients with Model for End-Stage Liver Disease (MELD) scores Υ 14 in comparison with remaining on the waitlist. The consensus of a 2003 transplant community national conference was that a minimum MELD score should be requi